-
For the Unstoppable Harmon Family, Every Day Is Father’s Day
June 11, 2013
… The Harmon Family Since his diagnosis with Parkinson’s disease (PD) in 2006 at 58, Bob Harmon and his entire family have sprung into action to help speed a cure in our lifetime. It started … at the National Institutes of Health. His experience as a research participant was so positive that he was among the …
-
Fox Flow: Taking Parkinson’s to the Mat — and Beyond
June 4, 2025
… program where 100 percent of funds raised go directly to research. Since her diagnosis in 2020, Shelley has been … as a small fundraiser with a $12,000 goal quickly turned into something much bigger. More than 200 attendees showed … end of the event, they had raised over $80,000 — and with nearly $20,000 more from their participation in MJFF's Tour …
-
Predicting Parkinson's Disease and Its Pathology via Simple Clinical Variables
January 21, 2022
… neurodegenerative disorder. Objective: To predict a future diagnosis of PD using questionnaires and simple non-invasive … deaths. We input simple clinical and risk factor variables into an ensemble-tree based machine learning algorithm and … considerably higher than estimates based solely on clinical diagnosis. …
-
Predicting Parkinson's Disease and Its Pathology via Simple Clinical Variables
September 29, 2021
… neurodegenerative disorder. Objective: To predict a future diagnosis of PD using questionnaires and simple non-invasive … deaths. We input simple clinical and risk factor variables into an ensemble-tree based machine learning algorithm and … considerably higher than estimates based solely on clinical diagnosis. …
-
Louisiana Volunteers Advocate and Fundraise for the Community
October 13, 2016
… in the community, she's helped pass legislation to increase research funding and secure better support services for … I've been a very active advocate for 15 years. BB: After my diagnosis, I had a pity party that lasted for a few months. … policy and advocacy forum in Washington, DC. She drew me into the fold. Within two weeks I was signed up and driving …
-
Phospho-proteome Analysis of PBMCs in LRRK2 Mutation Carriers: Expansion & Validation of Findings of the Barcelona LRRK2 Biorepository
… phosphorylation changes and evaluate their applicability as early disease biomarkers. Impact on Diagnosis/Treatment of Parkinson’s disease: Results from … be associated with disease status and disease progression into specific clinical outcomes in LRRK2-PD patients, and …